Skip to main content
PLOS One logoLink to PLOS One
. 2020 May 20;15(5):e0227786. doi: 10.1371/journal.pone.0227786

Frequency switching between oscillatory homeostats and the regulation of p53

Peter Ruoff 1,*, Nobuaki Nishiyama 2
Editor: Robert S Weiss3
PMCID: PMC7239446  PMID: 32433703

Abstract

Homeostasis is an essential concept to understand the stability of organisms and their adaptive behaviors when coping with external and internal assaults. Many hormones that take part in homeostatic control come in antagonistic pairs, such as glucagon and insulin reflecting the inflow and outflow compensatory mechanisms to control a certain internal variable, such as blood sugar levels. By including negative feedback loops homeostatic controllers can exhibit oscillations with characteristic frequencies. In this paper we demonstrate the associated frequency changes in homeostatic systems when individual controllers -in a set of interlocked feedback loops- gain control in response to environmental changes. Taking p53 as an example, we show how Per2, ATM and Mdm2 feedback loops -interlocked with p53- gain individual control in dependence to the level of DNA damage, and how each of these controllers provide certain functionalities in their regulation of p53. In unstressed cells, the circadian regulator Per2 ensures a basic p53 level to allow its rapid up-regulation in case of DNA damage. When DNA damage occurs the ATM controller increases the level of p53 and defends it towards uncontrolled degradation, which despite DNA damage, would drive p53 to lower values and p53 dysfunction. Mdm2 on its side keeps p53 at a high but sub-apoptotic level to avoid premature apoptosis. However, with on-going DNA damage the Mdm2 set-point is increased by HSP90 and other p53 stabilizers leading finally to apoptosis. An emergent aspect of p53 upregulation during cell stress is the coordinated inhibition of ubiquitin-independent and ubiquitin-dependent degradation reactions. Whether oscillations serve a function or are merely a by-product of the controllers are discussed in view of the finding that homeostatic control of p53, as indicated above, does in principle not require oscillatory homeostats.

Introduction

The concept of homeostasis is central to our understanding how organisms and cells adapt to their environments and thereby maintain their stability [13]. With the development of cybernetics [4, 5] control engineering concepts were, for the first time, applied to biological systems [6, 7]. With the advancement of molecular biology, robust control theoretic methods were applied at the molecular level, such as integral reign control [8], alongside with integral feedback [911], and systems biology methods [12, 13]. To achieve robustness of feedback controllers by integral control it became clear that certain reaction kinetic conditions need to be met. These conditions include zero-order kinetics [9, 10, 1419], autocatalysis [2022], and second-order (bimolecular/antithetic) reactions [23, 24], which were implemented into various controller motifs, synthetic gene networks, and other negative feedback structures [18, 2527].

A particular interesting aspect is that, under certain conditions, the homeostatic controllers may become oscillatory and preserve, if integral control is present, their homeostatic property by keeping the average value of the controlled variable at its set-point [28]. While the occurrence of oscillations is generally avoided in control engineering, oscillatory behavior is ubiquitously found in natural systems, exemplified by the adaptive properties of circadian and ultradian rhythms [2931].

In this paper we show how a set of inter-connected negative feedback loops maintain robust homeostasis in a controlled variable both under non-oscillatory and oscillatory conditions. We show that oscillatory controllers (negative feedback loops) may have specific frequencies and that frequency switching between different controllers occur dependent on the perturbation level of the controlled variable. We demonstrate how three combined negative feedback structures (see Materials and methods) reflect aspects of p53 regulation by involving the proteins Per2, ATM, and Mdm2. Dependent whether p53 degradation or synthesis is dominant, and dependent whether controllers are oscillatory, either low-level p53 circadian rhythms or higher-level p53 ultradian oscillations can be observed. However, whether oscillations serve a function or are merely a by-product of an oscillatory nature of the controllers is discussed in view of the finding that homeostatic control of p53 does in principle not require oscillatory homeostats.

Materials and methods

Computations were performed by using the Fortran subroutine LSODE [32] and Matlab (mathworks.com). Plots were generated with gnuplot (gnuplot.info) and edited with Adobe Illustrator (adobe.com). To make notations simpler, concentrations of compounds are denoted by compound names without square brackets and generally given in arbitrary units (au). Time derivatives are indicated by the ‘dot’ notation. Rate parameters are generally presented as ki’s (i = 1, 2, 3, …) irrespective of their kinetic nature. However, some KM’s (Michaelis constants), KI’s (inhibition constants), and Ka’s (activation constants) are emphasized when they are considered to play a role in the oscillatory and regulatory behavior of controllers. In the Supporting Information a set of Matlab (S1 Matlab), gnuplot, and avi-files (S1 & S2 Gnuplots) are provided to illustrate results.

The controller motifs used in this study

Drengstig et al. [18] suggested a basic set of eight 2-species negative feedback structures (termed controller motifs) with the incorporation of integral control. When analyzing the feedback structures between p53 and Per2, ATM, and Mdm2 we found that the three p53 feedback loops matched with the structures of motifs m3, m1, and m5, respectively (see more below).

The motifs (m1, m3, m5) are shown in Fig 1 A and Ei are the controlled and controller species, respectively. When integral control is invoked, the rate equations of the Ei’s (see below) define the different controllers’ set-points of A. Motifs m1 and m3 are termed inflow controllers. They oppose outflow perturbations of A by the Ei-induced compensatory reactions. Motif m5 is an outflow controller which opposes A-increasing perturbations by removing A due to E5.

Fig 1. The negative feedback loops m1, m3, and m5 used in this study.

Fig 1

Solid arrows indicate reactions/mass flow, while dashed lines indicate activating or inhibiting signaling events. A is the controlled variable, which is kept at a certain set-point by opposing (step-wise) perturbations in A. The Ei’s are controller species.

Rate constants have been arbitrarily chosen, but with the constraint that period lengths of the m3 and m5 oscillators are in the range of experimentally observed values, i.e. ca. 24h for the m3 (circadian Per2) oscillator and about 5h for the m5 (Mdm2) oscillator. The other used constraint concerns the chosen set-points for A of the three controllers. Set-points are chosen such that wind-up between controllers is avoided. See the chapter Synergy condition for coupled feedback loops later in the paper discussing this point.

Outline of the paper

In the first part of Results and discussion we describe how robust homeostasis can be achieved by a combination of inflow and outflow controllers using motifs m3 and m5 as an example. We show that controllers can operate both in a non-oscillatory and oscillatory control mode. In oscillatory mode, the individual controllers have, dependent on certain rate constants, characteristic inherent frequencies. When controllers become interlocked frequency changes will occur when during a perturbation a controller with a different frequency becomes dominant.

In the second part (starting with section p53 regulation by inflow and outflow control) we suggest how p53 in response to different stress-levels is homeostatically regulated by three interlocked oscillatory feedback loops which involve Per2 (no stress, motif m3), ATM* (medium stress, motif m1), and Mdm2 (high stress, motif m5) with the observed frequency/period changes from Per2-based circadian rhythms to m3/m5-based ultradian oscillations.

Results and discussion

Cannon’s definition of homeostasis and its realization by inflow and outflow controllers

The non-oscillatory case

Cannon defined homeostasis as the result of coordinated physiological processes, which maintain most of the steady states in organisms by keeping them within narrow limits [33]. One of the typical examples are human blood calcium levels, which, throughout our lifetimes are kept between approximately 9 to 10 mg Ca per dl blood. When levels are outside that range serious illness or death may occur.

The combination of inflow and outflow controllers having integral control [18] allows to keep a regulated variable within such strict limits. Fig 2 shows the arrangement between two collaborative controllers where the set-point of the inflow controller (Asetin) ensures for the lowest tolerable concentration of the controlled variable A, while the outflow controller does not allow that A-levels exceed the outflow controller’s set-point Asetout. It should be pointed out that not all inflow/outflow controller combinations [18] will lead to a set of collaborative controller pairs, because set-point values and the individual controllers’ on/off characteristics need to match; otherwise the controllers may work against each other and integral windup may be encountered [18], as described in more detail below.

Fig 2. Combination of inflow/outflow controllers (indicated by the transporters Ein and Eout) which keep a controlled variable A within the controllers’ set-points, independent of the perturbation parameters k1 and k2.

Fig 2

Fig 3 shows combined controller motifs m3 and m5 [18]. Feedback structure m3 is an inflow controller, while scheme m5 is an outflow controller where A is the controlled variable and k1 and k2 represent perturbations. To emphasize the inflow-outflow structure of the combined controllers E5 and E3 (Fig 1) are written as Eout and Ein, respectively.

Fig 3. Combination of controller motifs m3 and m5 with A as the controlled variable.

Fig 3

Rate parameters k1 and k2 are perturbations. KM and KM (in parentheses) are used when zero-order degradations with respect to A are studied and controllers become oscillatory (see next section). KI1 is an inhibition constant.

There are two separate conditions which have been applied on the controllers. One concerns the accuracy of the implemented integral control [14, 18] by using zero-order or near zero-order degradation/removal kinetics for the controller species Ei. This accuracy condition for integral control is independent of whether the controllers are oscillatory or not.

The other condition concerns the controllers’ oscillatory or non-oscillatory behaviors. When the degradation/removal reactions of A are first-order with respect to A the system is non-oscillatory. On the other hand, when degradations of A turn into zero-order kinetics with respect to A, the controllers become oscillatory without loosing the integral control part [16, 28].

For the non-oscillatory case the rate equation of A is:

A˙=k1k2·A+k6·Eink7·A·Eout (1)

Eout and Ein have the rate equations:

Eout˙=k3·Ak4·Eoutk5+Eout (2)
Ein˙=k8·KI1KI1+Ak9·Eink10+Ein (3)

High accuracy of the controllers is achieved when Eout and Ein are removed by zero-order (or near zero-order) kinetics, i.e. the rate parameters k5 and k10 in Eq 2 (m5 controller) and Eq 3 (m3 controller) satisfy the conditions k5Eout and k10Ein.

The controllers’ set-points, Asetout (for m5), and Asetin (for m3), are calculated by setting Eout˙ and Ein˙ to zero. Assuming k5Eout and k10Ein, we get:

Asetout=Asetm5k4k3 (4)
Asetin=Asetm3KI1(k8k9)k9 (5)

Fig 4 shows the steady state values of A, Eout, and Ein as a function of the perturbation parameters k1 and k2. It shows that the combined controllers in Fig 3 can keep variable A between the set-points of the m3 and m5 controllers. In Fig 4a the red color indicates the A values that are close to or at the set-point of the outflow controller m5 (Asetout), while the purple color shows the A values close to or at set-point for inflow controller m3, Asetin. Note the corresponding up- and downregulation of Eout and Ein in Fig 4b.

Fig 4. Steady state values of A, Eout, and Ein of the combined m3-m5 controllers (Fig 3) as a function of perturbation parameters k1 and k2. k1 and k2 vary between 1.0 and 50.0 with increments of 1.0.

Fig 4

(a) Steady state values of A. Numbers 1-5 in the plot indicate the contour lines having this value of Ass. (b) Steady state values of Eout and Ein. Rate constants: k3 = 10.0, k4 = 50.0, k5 = 1 × 10−6, k6 = k7 = 1.0, k8 = 2.0, k9 = 1.0, k10 = 1 × 10−6, KI1 = 1.0. Initial concentrations when calculating Ass for each k1, k2 pair: A0 = 3.0, Ein = Eout = 0.0; integration time: 1000 time units. For an interactive visualization of the surfaces, see S1 Gnuplot.

Oscillatory control mode

When the degradation reactions become zero-order with respect to A the rate equation of A becomes

A˙=k1k2·AKM+A+k6·Eink7·A·EoutKM+A (6)

with KM,KMA. In this case both the m3 and the m5 controllers become oscillatory. For the m5 feedback loop the oscillations can approximately be described by a harmonic oscillator [16] with estimates of period length Pm5 and amplitudes Aampl, Eoutampl as

Pm5=2πk3k7 (7)
Aampl=2×H5,0+αc (8)
Eoutampl=2×H5,0+αa (9)

where a = 0.5 × k7, b = k1 + k6k2, c = 0.5 × k3, d = k4, and α = (d2/4c) + (b2/4a). Due to a misprint in Ref [16] for the harmonic oscillator solution of controller m5, S1 Text gives the derivations of Eqs 79.

Also for the m3 feedback loop a “harmonic oscillator approximation” [28] can be found for the period Pm3 with semi-analytic expressions for the amplitudes. Dependent whether one starts to calculate A¨ or Ein¨ in deriving Pm3, two interrelated expressions for Pm3 are obtained, respectively:

Pm3=2πk6k8KI1(KI1+<A>) (10)

or

Pm3=2π(k6k9KI1+<A>) (11)

where <A> is the average value of A defined as

<A>=1τ0τA(t)dt (12)

See S1 Text for details.

Fig 5 shows a comparison between combined controllers m3 and m5 when using for A Eq 1 (Fig 5a) and when using Eq 6 (Fig 5b). In phase 1 the outflow perturbation k2 is largest (k1 = 1.0, k2 = 10.0) while in phase 2 the inflow perturbation is largest (k1 = 10.0, k2 = 0.0). Rate constant values have been chosen such that during phase 1 the dominating inflow controller (m3) has a period of 24 time units (Fig 5c), while during phase 2 the dominating outflow controller (m5) has a period of approximately 5 time units (Fig 5d). These rate constant values also take part in defining the set-point for the inflow controller m3 to Asetin=1.7 (Eq 5) and the set-point of the outflow controller m5 to Asetout=16.7 (Eq 4).

Fig 5. Comparison between oscillatory and non-oscillatory controller modes of combined motifs m3 and m5.

Fig 5

(a) non-oscillatory behavior when rate of A is given by Eq 1. (b) Oscillatory behavior when describing A˙ by Eq 6. (c) Comparison between oscillatory and non-oscillatory behavior in phase 1 when k1 = 1.0 and k2 = 10.0. Average value of oscillatory A, <A>, is precisely at Asetin=1.7. (d) Comparison between oscillatory and non-oscillatory behavior in phase 2 when k1 and k2 have changed to respectively 10.0 and 0.0. <A> (blue line), approaches rapidly the set-point of the outflow controller Asetout=16.7. Other rate constants: k3 = 3.0, k4 = 50.0, k5 = 1 × 10−8, k6 = 0.7, k7 = 0.5, k8 = 1.2, k9 = 1.0, k10 = 1 × 10−6, KM,KM (when applied) both 1 × 10−6, and KI1 = 8.5. Initial concentrations for phase 1, panel a: A0 = 1.700, Eout,0 = 1.136 × 10−9, Ein,0 = 2.286 × 101; Initial concentrations for phase 1, panel b: A0 = 3.219, Eout,0 = 2.395 × 10−9, Ein,0 = 1.322 × 101.

In the oscillatory control mode (Eq 6) the period of the dominant (ruling) controller is established (Fig 6a), dependent whether inflow perturbation k1 or outflow perturbation k2 dominates. The A, Ein amplitudes of the inflow controller m3 are practically constant and independent of the level of perturbation (k2), while for outflow controller m5 amplitudes increase with increasing perturbation strength k1 (Fig 6b). S1 Text gives approximative analytical expressions for the m3 and m5 oscillators’ amplitudes. Interestingly, oscillations stop when k1 and k2 values are equal. Fig 6c shows that the oscillatory controllers follow (on average) closely the controllers’ set-points of the non-oscillatory state (Eqs 4 and 5). Fig 6d shows the changes of the average values of respectively Ein and Eout (<Ein> or <Eout>) in dependence of k1 and k2.

Fig 6. Overview of the oscillatory properties of combined motifs m3 and m5.

Fig 6

(a) The period switches in dependence whether the inflow or the outflow controller is dominating. (b) Amplitude of the A-oscillations. (c) The controllers’ <A> values follow closely their set-points. (d) Average values of the oscillatory Ein and Eout concentrations and their up-regulation in dependence of the perturbations. Rate constants and initial concentrations as for the oscillatory case in Fig 5. All properties were calculated after 500 time units when (oscillatory) steady state conditions were established. See also S2 Gnuplot for an interactive visualization of each panel.

p53 regulation by inflow and outflow control

p53 is a protein often described as the “guardian of the genome” [34]. p53 takes part in cell fate decisions [35] with respect to internal or external environmental disturbances and is involved in cell cycle arrest. p53 is also considered to prevent tumor development by inducing apoptosis in response to DNA-damage and other stress signals [36].

In normal unstressed cells p53 is at low levels due to different proteasomal degradation reactions including ubiquitin-dependent [37] and ubiquitin-independent [3840] pathways. For the ubiquitin-independent pathways the enzyme NAD(P)H:quinone oxidoreductase 1 (NQO1) has been indicated to have a major regulatory role [41, 42]. In unstressed cells there is further evidence that p53 and the circadian clock [30] undergo cooperative regulations [4346] via the Per2 protein. Per2 is not only an important component of the human circadian oscillator [47], but also takes part in the input and output pathways of the clock [48]. Under normal (unstressed) conditions p53 has been found to inhibit expression of Per2 by binding to its promotor [43]. Overexpressing Per2 in HCT116 cells resulted in a significant increase in p53 mRNA [43] or in an induced apoptosis in lung cancer cells [49], indicating that Per2 can activate the synthesis of p53. In addition, due to its binding to p53, Per2 has been found to inhibit the Mdm2-mediated degradation of p53 which leads to a stabilization of p53. This Per2-p53 feedback loop has the typical properties of an inflow type of controller and has the same basic structure as the m3 loop in Fig 3. This suggests that p53 is kept by the circadian clock at an acceptable minimum (“preconditioning” [45]) level with set-point p53min, which allows a sufficiently rapid up-regulation of p53 in the case of stress/DNA-damage.

In case of stress/DNA-damage p53 is up-regulated by ataxia telangiectasia mutated (ATM) kinase [50, 51]. The treatment of human MCF7/U280 cell lines with 10 Gy gamma radiation showed oscillations in p53 and Mdm2 with a period length of about 5-6 hours [52]. An interesting feature of these oscillations is that their period is relatively stable, while there is a considerable variation in their amplitudes. It has also been pointed out [52] that a significant fraction of the MCF7/U280 cells (about 40% at 10 Gy) do not oscillate, i.e., either showed no variations in p53 or showed only slowly varying fluctuations. In analyzing the p53-Mdm2 negative feedback loop, Jolma et al. [16] found that the loop can show harmonic oscillations when the respective degradations of p53 and Mdm2 approach zero-order. The conservative feature of these oscillations not only could explain the constancy of the period and the stochastic variation in the amplitude, but as a motif 5 outflow controller [18], the set-point of the p53-Mdm2 loop provides an upper p53 concentration limit, probably to avoid a premature apoptosis of cells.

A Fourier analysis of the p53 oscillations [53] showed indeed a major harmonic peak at about 5-6h along with minor 2nd and 3rd-order harmonics at lower periods. The rise of the Fourier transform at higher period lengths (>10h) provides evidence for an additional loop, which Geva-Zatorsky et al. [53] considered to be a feedback loop between ATM and p53. In this feedback loop the active (phosphorylated) form of ATM (ATM*) activates p53 via CHK2 (checkpoint kinase 2) [51, 54], while p53 inhibits ATM* via the activation of phosphatase WIP1 [51, 55, 56]. A closer look at the p53-ATM* loop shows that it acts as a motif m1 ([18]) inflow controller. The inflow control function of this loop suggests that the loop’s set-point, p53minstress, keeps the p53 concentration in stressed cell at a minimum level, but higher than the set-point imposed by the circadian clock. As we will show below the set-point defined by the ATM* controller increases with the stress level, i.e. shows rheostasis [57], and counteracts perturbations which may accidentally drive p53 to lower levels.

Based on these observations we arrive at a p53 homeostatic model of three interlocked feedback loops with period lengths of p53 oscillations which are dependent on the stress level and the ruling feedback loop responding to it. Fig 7 shows a schematic representation of the model. In unstresssed cells the inflow control properties of the p53-Per2 feedback loop, analogous to motif m3, ensures that p53 is on average at a minimum low level (with set-point p53setPer2) compensating for the proteasomal ubiquitin-independent degradations of p53 via NQO1. In stressed cells, several factors increase the level of p53, including its activation by ATM, the inhibition of the ubiquitin-independent degradation pathways of p53, and the stabilization of p53 by chaperones such as HSP90. The inflow control structure between p53 and the activated ATM loop (motif 1) now drives p53 levels up to p53setATM*. As stabilization and concentration of p53 further increases, the Mdm2-p53 control loop (motif 5) will oppose further increase of p53, at least temporarily. However, since the set-point of this controller (p53setMdm2) is given by the ratio between synthesis and degradation rates of Mdm2, the set-point of the Mdm2-controller may further increase when Mdm2 is stabilized by chaperones/HSP90 and the Mdm2 turnover is inhibited [58].

Fig 7. Hierarchical regulation of p53 by Per2, ATM*, and Mdm2 in unstressed and stressed cells.

Fig 7

Outlined in blue is the regulation of p53 in unstressed cells, where Per2, acting as an inflow regulator, keeps p53 at a low “preconditioning” level [45]). In the presence of cell stress ATM* is upregulated (outlined in orange). The rheostatic set-point [57] of this inflow controller increases with increasing cell stress until control by Mdm2 at higher stress levels (outlined in purple) opposes a further increase of the p53 level. Schemes to the right show the color-coded active control loops and the grayed inactive ones.

Fig 8 shows the reaction scheme of the model for unstressed and stressed cells. The model consists of 9 coupled rate equations. Dependent on the stress level, reactions outlined in light gray are low in their reaction rates/concentrations, while reactions outlined in black are the dominating ones. For the sake of simplicity we used the single variable s to mediate the stress into the network, both for the activation of ATM (with activation constant Kas) and the inhibition of the NQO1-mediated proteasomal degradation of p53 (with inhibition constant KIs). In addition, we also include a stress-related increase of p53 via k1 in parallel to its activation by ATM*. This additional activation may be related due to the presence of reactive oxygen species [59], although the reaction pathways, as indicated by the question mark, are not well understood.

Fig 8. Model of the three interlocked feedback loops regulating p53.

Fig 8

In unstressed cells (left panel) the m3-loop is active (outlined by the blue area) in which Per2, coupled to the circadian pacemaker, ensures a minimum level of p53. The other controllers (m1 and m5, outlined in gray within their respective orange and purple areas) remain inactive. In stressed cells (right panel) the ATM*-based m1 controller becomes first active (orange area) while the p53-interacting Per2 is downregulated, but without affecting the circadian rhythmicity of Per1 and Bmal/Clk. With increasing cell stress (described by parameter s) Mdm2 is upregulated (purple area). The Mdm2 controller opposes an increase of p53 above the Mdm2 set-point, possibly to avoid premature apoptosis. For rate equations, see main text.

The activation of ATM to ATM* by the stress level s is described by the rate equation

ATM*˙=k26·sKas+s(k27·ATM*k28+ATM*)·p53 (13)

The rate equation for p53 consists of four inflows and two outflows (Fig 8).

p53˙=k31+k1sKas+s(k2·p53KM+p53)·(KIsKIs+s)+k29·ATM*+k6·Per2(k7·p53KM+p53)·(KI2KI2+Per2)·Mdm2 (14)

The first term, k31, is a constitutive (constant) expression term for p53 [60], while the second and third terms represent, respectively, stress-induced activation of p53 production and a stress-induced inhibition of the proteasomal ubiquitin-independent degradation of p53 via NQO1.

The remaining rate equations are:

Mdm2˙=k3·p53k4·Mdm2k5+Mdm2 (15)
Per2˙=k8·(KI1KI1+p53)·(Bmal/ClkKa+Bmal/Clk)k9·Per2k10+Per2k17·Per1·Per2+k18·(Per1Per2)2k24·(Per2)2+2k23·(Per22) (16)
Bmal/Clk˙=k11·(KI3KI3+(Per1Per2))·(KI4KI4+(Per12))·(KI5KI5+(Per22))k12·Bmal/Clkk13+Bmal/Clk (17)
Per1˙=k14·Bmal/Clkk15·Per1k16+Per1k17·Per1·Per2+k18·(Per1Per2)2k20·(Per1)2+2k21·(Per12) (18)
d(Per1Per2)dt=k17·Per1·Per2(k18+k19)·(Per1Per2) (19)
d(Per12)dt=k20·(Per1)2(k21+k22)·(Per12) (20)
d(Per22)dt=k24·(Per2)2(k23+k25)·(Per22) (21)

As indicated by Fig 7 p53 is controlled in this model by three feedback loops. Rate parameters have been chosen such that each of the feedback loops has integral control/feedback with defined set-points and, when oscillatory, defined period lengths.

In the absence of stress p53 is rapidly degraded by the proteasome. In this case Per2 acts as an inflow controller with a set-point given by Eq 5, i.e.,

p53setPer2=KI1(k8k9)k9 (22)

Since we assume that the degradation reaction of p53 are zero-order with respect to p53, the Per2 controller oscillates around p53setPer2 with a period described by Eq 10, i.e.,

Pp53Per2=2πk6k8KI1(KI1+p53min) (23)

The values of k6 (0.7), k8 (1.2), KI1 (8.0), and k9 (1.0) have been chosen such that p53setPer2 is relatively low, i.e., 1.6. Pp53Per2 is thereby in the circadian range (≈24h).

Per2, which takes part in the regulation of p53 in unstressed cells, is an important component of the mammalian circadian clock [48]. In Fig 8 we have included a relatively simple model of the mammalian circadian pacemaker, where Per2 together with Per1 take part in a transcriptional-translational negative feedback loop. In this negative feedback the protein complex between Bmal1 and Clock (Bmal/Clk) activates the transcription of Per1 and Per2. Per1 and Per2, on the other hand, inhibit their own, by Bmal/Clk induced, transcription. By binding to PAS domains [61] homo- and heterodimers between Per2, Per1, and other protein complexes are formed which take part in the inhibition of the transcriptional activity of Bmal/Clk [47]. In the circadian pacemaker part of the model (Fig 8) we included the formation of heterodimers between Per2 and Per1, as wells as the formation of homodimers of Per2 and Per1. In the above equations (Per12) and (Per22) denote the respective concentrations of the Per1 and Per2 homodimers, while (Per1⋯Per2) denotes the concentration of the Per1-Per2 heterodimer.

When stress is present, but not too high (0.1 ≤ s ≤ 1), ATM* determines the average concentration of p53 and the frequency of the p53 oscillations. By setting Eq 13 to zero and assuming zero-order degradation of ATM* with respect to ATM* the set-point of p53 determined by this controller is dependent on the stress level s, i.e.,

p53setATM*=k26k27·(sKas+s) (24)

Rate parameters k26 (90.0), k27 (10.0), and Kas (3.0) have been chosen such that p53setATM* has a maximum value of 9.0 when s is high. This value has been arbitrarily chosen, with the only requirement that p53setATM* should be higher than p53setPer2. The ATM* controller’s period (being a m1 controller) is calculated to be (S2 Text):

Pp53ATM*=2πk27k29 (25)

Using, rather arbitrarily k29 = 1.0, the period of the ATM* controller is approximately 2h.

For high stress levels (s > 1) the Mdm2 outflow controller keeps p53 at a much higher set-point analogous to Eq 4, i.e.,

p53setMdm2=k4k3 (26)

Ignoring the influence of noise [16], p53 oscillates now around the set-point described by Eq 26 with period

Pp53Mdm2=2πk3k7 (27)

Using values of k3 and k7 of respectively 3.0 and 0.5 the period of the Mdm2 controller is 5.1h. With k4 = 50.0 the value of p53setMdm2 is 16.6 and defines an upper bound of the p53 concentration. How this upper bound can be further increased and finally may lead to apoptosis will be discussed below.

Fig 9 shows how the steady state period and average levels of p53 change with the stress signal s. At certain stress levels the controllers Per2, ATM*, and Mdm2 are individually up-regulated. They defend their set-points and frequencies of the p53 oscillations. Mrosovsky [57] termed the defense of different environmentally-induced set-points as “reactive rheostasis”.

Fig 9. Change of steady state levels in the model (Fig 8) as a function of stress level s.

Fig 9

(a) Change of k1,act (Eq 28) and k2,inhib (Eq 29), (b) p53 period length, (c) average p53 concentration <p53>; inset: same figure, but abscissa (s) is linear. (d) average Per2 concentration <Per2>, (e) average ATM* concentration <ATM*>, and (f) average Mdm2 concentration <Mdm2>. Parameter values: k1 = k2 = 10.0, k3 = 3.0, k4 = 50.0, k5 = 1 × 10−6, k6 = 0.7, k7 = 0.5, k8 = 1.2, k9 = 1.0, k10 = 1 × 10−6, k11 = 0.85, k12 = 0.7, k13 = 1 × 10−6, k14 = 1.0, k15 = 0.7, k16 = 1 × 10−6, k17 = k18 = 1 × 103, k19 = 0.0, k20 = 10.0, k21 = 0.5, k22 = 0.0, k23 = 1 × 106, k24 = 1 × 103, k25 = 0.0, k26 = 90.0, k27 = 10.0, k28 = 1 × 10−6, k29 = 1.0, k31 = 1.0, KM = 1 × 10−6, KI1 = KI3 = KI4 = KI5 = 8.0, KI2 = 1 × 106, KIs = 3.0, Ka = 0.012, Kas = 3.0. Initial concentrations: p530 = 1.49, Mdm20 = 9.84 × 10−8, Per20 = 3.82 × 10−2, Bmal/Clk0 = 1.00, Per10 = 1.48 × 10−1, Per1⋯Per20 = 5.66 × 10−3, (Per12)0 = 1.82 × 10−1, (Per22)0 = 1.46 × 10−6, ATM0*=8.46. Steady state levels were recorded after 3000 time units (h).

In Fig 9a we suggest how a stress-induced inflow to p53 (second term in Eqs 14 and 28) and a stress-induced inhibition of p53-degradation (third term in Eqs 14 and 29) may change with stress level s.

k1,act=k1·(sKas+s) (28)
k2,inhib=k2·(KIsKIs+s) (29)

Panels b and c show how the individual controllers, dependent on the stress level, determine p53’s period length and average level. Panels d-f show the controllers Per2 (d), ATM* (e), and Mdm2 (f) and their abrupt up/downregulation at different stress levels.

Fig 10 shows the steady state oscillations at four different stress levels. Panel a shows the Per2 and p53 oscillations at low/no stress. In agreement with experiments [45] Per2 peaks a couple of hours earlier than p53. As indicated by Fig 9b, 9c and 9d Per2 has control over p53 rhythmicity and its level in unstressed cells. In Fig 10b, at minor stress levels, we see the Per2 and p53 oscillations near the transition to ATM* control, which is indicated by the appearance of short period oscillations in p53 due to the influence of the ATM* controller. Fig 10c shows the oscillations when the ATM* concentration is relatively high (Fig 9e), while in panel d the Mdm2 controller has taken over and is determining the level and period length of the p53 oscillations (see also Fig 9f which shoes the Mdm2 upregulation).

Fig 10. Steady state oscillations of p53 and Per2, together with <p53>, at different stress levels s.

Fig 10

Parameter values are the same as in Fig 9. (a) Oscillatory behavior when s = 1 × 10−4 (low stress level). Per2 determines the state of p53. Initial concentrations: p530 = 7.65 × 10−1, Mdm20 = 4.82 × 10−8, Per20 = 1.36 × 101, Bmal/Clk0 = 0.39, Per10 = 7.34 × 10−2, (Per1⋯Per2)0 = 1.00, (Per12)0 = 2.21 × 10−1, (Per22)0 = 1.86 × 10−1, ATM0*=3.92×1010. (b) s = 1 × 10−1. The high frequency oscillations of the ATM* controller begin to appear, but the Per2 controller still determines p53 period length. Initial concentrations: p530 = 1.11, Mdm20 = 7.12 × 10−8, Per20 = 1.26 × 101, Bmal/Clk0 = 0.47, Per10 = 8.44 × 10−2, (Per1⋯Per2)0 = 1.06, (Per12)0 = 2.35 × 10−1, (Per22)0 = 1.58 × 10−1, ATM0*=3.55×107. (c) s = 1.0. ATM* is the ruling controller and p53 oscillates with a period of 2h (Eq 25) around the controller’s set-point p53setATM*=2.25 (Eq 24). Initial concentrations: p530 = 2.58, Mdm20 = 1.83 × 10−7, Per20 = 5.56 × 10−6, Bmal/Clk0 = 0.17, Per10 = 3.55 × 10−1, (Per1⋯Per2)0 = 1.98 × 10−6, (Per12)0 = 3.03, (Per22)0 = 3.10 × 10−14, ATM0*=6.26. (d) s = 10.0. Mdm2 is the dominant controller. p53 oscillates with a period of 5.1h (Eq 27) around a set-point of 16.6 (Eq 26). Initial concentrations: p530 = 21.85, Mdm20 = 1.17 × 101, Per20 = 4.54 × 10−7, Bmal/Clk0 = 0.41, Per10 = 4.03 × 10−1, (Per1⋯Per2)0 = 1.83 × 10−7, (Per12)0 = 3.52, (Per2)2,0 = 2.06 × 10−16, ATM0*=4.64×107.

Each of the three controllers, Per2, ATM*, and Mdm2, defend their set-points. As inflow controllers Per2 and ATM* compensate for outflow perturbations, for example by an accidental increase of k2, while the Mdm2 controller will oppose any further increase of p53.

As an example we show the homeostatic/rheostatic behavior of the ATM* controller. The set-point of the ATM* controller, which depends on the stress level s (Eq 24), is defended towards an increase in p53 outflow. Fig 11a shows the behavior of the p53 oscillations when s = 1.0 (corresponding to Fig 10c) and k2 undergoes a perturbation at t = 20h from 10.0 to 50.0. The set-point of the controller (2.25) is defended by an upregulation of ATM*, as seen in Fig 11b. Also the period (taken here arbitrarily as 1.99h, Eq 25) is kept constant (Fig 11b). Fig 11c shows the circadian oscillations of Per1 and Bmal/Clk, which are unaffected by the perturbation in k2 and keep a phase relationship in agreement with experimental results [62].

Fig 11. The ATM* controller defends its s-dependent set-points (Eq 24) towards outflow perturbations.

Fig 11

Row a, left panel: p53 oscillations and average p53 levels, <p53>, as a function of time with s = 1.0. At time t = 20h k2 is increased from 10.0 to 50.0. Row a, right panel: average p53 concentration is back at the controller’s set-point (2.25) with an unchanged period length of 1.99h. Row b, left and right panels: Upregulation of ATM* due to the change in k2. Row c, left and right panels: oscillations in Per1 and Bmal/Clk are unaffected by the k2 perturbation. Initial concentrations and rate parameters as in Figs 10c and 9.

Synergy conditions for coupled feedback loops

There are certain requirements that need to be met such that a set of coupled negative feedback motifs will cooperate and work together. As pointed out in [18] a cooperative interaction between a set of negative feedback loops will depend on how the set-points of the individual controllers (determined by their Ei˙’s) are positioned relative to each other within the concentration space of the controlled variable A. Fig 12 shows the rate equations and the corresponding sign structures of the Ei˙’s from Fig 1 for the m1, m3, and m5 controllers.

Fig 12. Rate equations of the Ei’s (Fig 1) and their corresponding sign structures Ei˙ for the three controllers m1, m3, and m5 with set-points Aset,i.

Fig 12

Reactions with “p” indicate perturbations. When the controlled variable A is at its set-point (A = Aset,i) we have that Ei˙=0. When Ei˙>0 the controllers are active, i.e. inflow controllers m1 and m3 add more A to the system, while outflow controller m5 removes A from the system. When Ei˙<0 controllers become inactive and the Ei’s and their compensatory fluxes go to zero/low values.

For example, when a m1 and a m5 controller (Fig 13a) are coupled such that Aset,1 < Aset,5 the controllers will cooperate and either m1 or m5 will dominate dependent on the perturbation acting on A. However, when Aset,1 > Aset,5 the two controllers will work against each other, as indicated in Fig 13b. Both controllers are in an “on-state” with the effect that E1 and E5 increase continuously, a situation termed in control engineering as integral wind-up [63]. For details, see S3 Text.

Fig 13. Cooperative and dysfunctional wind-up behavior in combined negative feedback loops.

Fig 13

(a) Combined controllers m1 and m5 (S3 Text). (b) Wind-up behavior when Aset,1 > Aset,5. Because E1˙ and E5˙ meet each other in this case with positive signs, each controller pulls in the direction of its own set-point (gray arrows). As a result, E1 and E5 increase continuously and the controlled variable A lies somewhere between the two set-points dependent on the individual aggressiveness [18] of m1 and m5. S3 Text shows in addition the cooperative behaviors of the two controllers when set-points are switched. (c) Cooperative behavior of the Per2, ATM*, and Mdm2 controllers with respect to p53 regulation. Gray arrows show the direction in p53-concentration space into which each controller pulls.

The structures of the interacting negative feedback loops shown in Figs 7 and 8 have been taken from the literature (see references cited above). Fig 13c shows the relative setting of the set-points in the p53 concentration space for the Per2, ATM*, and Mdm2 controllers and their sign structures. It appears encouraging that these feedback loops can be placed in a naturally occurring order in p53 concentration space without wind-up.

Roles of the individual feedback loops

The spacing of the controllers in Fig 13c suggests that the three feedback loops have certain functions in the regulation of p53. As an inflow controller, the Per2-p53 feedback loop has the apparent function to keep p53 in unstressed cells at a certain minimum level in order to allow a sufficiently rapid p53 upregulation [44] in case DNA damage occurs.

In case of DNA damage, the ATM*-p53 loop, is up-regulated. This loop keeps p53 at a higher set-point dependent on the stress level s. The ATM* controller defends its set-point towards increased degradations of p53 as long as stress is encountered. This suggests that as long as DNA-stress is present, the ATM*-loop ensures that p53 is not decreased due to stress-unrelated or accidental degradations of p53. In a way the ATM*-loop acts as a one-way concentration valve, not allowing that p53 concentrations are decreased below a certain minimum level. The stress-dependent increase of the p53 set-point by the ATM*-p53 loop is a nice example of what Mrosovsky [57] has termed rheostasis. Rheostasis is defined as a homeostatic system when the set-point is changed but defended in relationship to a changed external or internal environmental condition or due to stress. A typical example of rheostatic regulation is the defended increase of body temperature (fever) due to an infection. For more examples of rheostasis, see Ref [57].

As indicated earlier [16], the role of the Mdm2-p53 loop seems to avoid premature apoptosis by counteracting uncontrolled rises of p53 above the Mdm2-determined set-point. However, the set-point of the Mdm2-p53 controller does not seem to be fixed. Peng et al. [58] found that treating DLD1 cells with the DNA-damaging agent camptothecin (CPT) led to a decrease in Mdm2 levels. The authors’ interpretation was that Mdm2 degradation under DNA-stress is actually promoted. Such an increase in the Mdm2 degradation (k4) by DNA-damaging conditions would lead to an increased p53 set-point of the Mdm2 controller (Eq 26), which ultimately could reach apoptotic p53 levels. Chaperones and HSP90 lead to an additional stabilization of p53.

Thus, our model suggests that the individual feedback loops act as temporary stabilizers of p53 when DNA stress is encountered. They result in a gradual step-wise increase in p53 concentration, where each step is under homeostatic (rheostatic) control. When DNA repair is successful and stress levels are removed, p53 concentration falls back to its minimum set-point determined by the Per2-p53 loop. In principle, additional, not yet identified negative feedback loops of p53 with other controllers could be involved in such a rheostatic regulation of p53 during DNA stress. Considering the “plethora of proposed feedback interactions” of p53 [64], an investigation of additional feedbacks in terms of their inflow/outflow behavior may provide further insights and novel suggestions about the workings between different controllers in the p53 network.

Why oscillations?

The here presented homeostatic (rheostatic) model on how p53 levels are controlled does not necessarily need to involve oscillations. As shown in Fig 5 both the oscillatory and the non-oscillatory versions of the coupled homeostats work equally well. The same goes for the p53 system (Fig 9) when the ATM* and Mdm2 controllers are in a non-oscillatory mode (S4 Text). Thus, sustained or damped oscillations could simply be a byproduct of the negative feedback loops. What supports partly such a view is that a large fraction of γ-irradiated cells (≈ 40%) do not show oscillations [52] and that there is a considerable heterogeneity of p53 dynamics even in genetically identical cells [64]. The various proteasomal p53 degradation pathways, which have been discovered [3739], may provide an explanation why some cells show oscillations while others don’t. The pathways may differ in their binding strength between p53 and the different proteasomal proteins. In non-oscillatory cells the proteasomal degradation pathway may have a weak binding between p53 and pathway proteins/enzymes (which determine the rate of p53 degradation), and which would lead to a high overall KM and to approximately first-order p53 degradation kinetics. In oscillatory cells, on the other hand, the dominant proteasomal degradation pathway may have a tighter binding between p53 and proteasomal proteins with the result of overall lower KM values and close to zero-order degradation kinetics. As long as ATM* and Mdm2 contain integral feedback loops one would expect the same regulatory outcome independent of the p53-degradation kinetics, i.e. whether feedback loops are oscillatory or not. The large heterogeneity of p53 dynamics seems to indicate that there is no selective advantage whether homeostatic control of p53 in some instances occurs oscillatory while under other conditions it does not. Porter et al. found that physiologically relevant DNA damage responses apparently begin already after very few p53 pulses or even before the first p53 pulse is completed, and that coordination of p53 target genes increases with successive p53 pulses [65]. This observation can be interpreted in such a way that the coordination of p53 target genes become established when p53 approaches a stress-level dependent steady state/set-point with the suggested [51] possibility that p53 pulses and their dynamics trigger different signal transduction pathways.

There is also the possibility that some controllers (for example Per2 and Mdm2) are oscillatory (due to zero-order degradation with respect to p53), while the ATM* feedback loop is non-oscillatory (due to first-order degradation of p53). This would explain the observation that certain cells, by being less susceptible towards gamma irradiation, are controlled by ATM* and thereby are non-oscillatory, while in other cells, which are more sensitive towards irradiation, p53 is controlled by Mdm2 and shows oscillations.

Summary and conclusion

We have shown that oscillatory homeostats can impose specific frequencies on the oscillations of a controlled variable. In case of perturbations or stress acting on the controlled variable a switch between one oscillatory controller to another is accompanied by a corresponding switch in frequency through the controlling feedback. By analyzing the inflow/outflow control structures of three p53 negative feedback loops (Per2, ATM*, and Mdm2) we were able to assign certain functionalities to each of them. Per2 provides circadian inflow control over p53 by keeping it at the lowest set-point level, ensuring that p53 can be rapidly up-regulated in case of DNA damage/stress. In case of DNA damage the ATM*-p53 feedback loop, another inflow controller, leads to increased p53 levels depending on the stress level. Since the ATM*-induced p53 concentrations are under homeostatic control and defended, the ATM*-p53 feedback loop provides a nice example of what Mrosovsky has termed rheostasis. As an outflow controller, the Mdm2-p53 loop does not allow that p53 levels are raised above the controller’s set-point, probably to avoid premature apoptosis. However, additional mechanisms, such as chaperones and heat shock proteins, in particular HSP90, seem to increase Mdm2’s set-point and stabilize p53 at a higher level, which finally may lead to apoptosis.

We have considered here only negative feedback loops without the addition of feedforward or positive feedback. While the circadian rhythms show limit-cycle behavior, the p53/ATM* and p53/Mdm2 oscillations are conservative. Including positive feedbacks into the model will certainly make changes in the network’s dynamics and may lead to limit cycle behavior where conservative oscillations are presently observed. However, we do not think that the qualitative (homeostatic) properties of the interacting negative feedback loops will be significantly altered. Although the p53 model presented here is a far cry from what seems to go on in a real cell, the inflow/outflow approach and the conditions how negative feedback loops can interact without dysfunctional behavior (wind-up) appears to be an alternative and novel aspect how to analyze the organization of feedback loops in cells and organisms.

Supporting information

S1 Matlab. Matlab programs.

A zip-file with Matlab programs showing the results from Figs 5a, 5b, 10a–10d and 11a–11c (left panels).

(ZIP)

S1 Gnuplot. Interactive visualization.

A zip-file with a gnuplot script and an avi video file showing an interactive view of Fig 4.

(ZIP)

S2 Gnuplot. Interactive visualization.

A zip-file with a gnuplot script and avi video files showing interactive views of panels a-d in Fig 6.

(ZIP)

S1 Text. Harmonic approximation of period lengths and amplitudes of oscillatory m3 and m5 controllers.

(PDF)

S2 Text. Determination of set-point and period length of the ATM* controller.

(PDF)

S3 Text. Combined m1 and m5 controllers and their cooperative and wind-up behaviors.

(PDF)

S4 Text. Steady state levels of the model as a function of stress level s when feedback loops are non-oscillatory.

(PDF)

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The authors received no specific funding for this work.

References

  • 1. Cannon W. The Wisdom of the Body Revised and Enlarged Edition. New York: Norton; 1939. [Google Scholar]
  • 2. Langley LL, editor. Homeostasis Origins of the Concept. Stroudsbourg, Pennsylvania: Dowden, Hutchinson & Ross, Inc; 1973. [Google Scholar]
  • 3. Clancy J, McVicar A. Physiology and Anatomy A Homeostatic Approach. Second edition Arnold; 2002. [Google Scholar]
  • 4. Ashby WR. An Introduction to Cybernetics. Chapman & Hall Ltd; 1961. [Google Scholar]
  • 5. Wiener N. Cybernetics: or Control and Communication in the Animal and the Machine. Second Edition Cambridge, Massachusetts: The MIT Press; 1961. [Google Scholar]
  • 6. Milsum JH. Biological Control Systems Analysis. New York: McGraw-Hill; 1966. [Google Scholar]
  • 7. Milhorn HT. Application of Control Theory to Physiological Systems. Philadelphia: WB Saunders; 1966. [Google Scholar]
  • 8. Saunders PT, Koeslag JH, Wessels JA. Integral rein control in physiology. J Theor Biol. 1998;194(2):163–173. 10.1006/jtbi.1998.0746 [DOI] [PubMed] [Google Scholar]
  • 9. Barkai N, Leibler S. Robustness in simple biochemical networks. Nature. 1997;387(6636):913–7. 10.1038/43199 [DOI] [PubMed] [Google Scholar]
  • 10. Yi TM, Huang Y, Simon MI, Doyle J. Robust perfect adaptation in bacterial chemotaxis through integral feedback control. PNAS. 2000;97(9):4649–53. 10.1073/pnas.97.9.4649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. El-Samad H, Goff JP, Khammash M. Calcium homeostasis and parturient hypocalcemia: an integral feedback perspective. J Theor Biol. 2002;214(1):17–29. 10.1006/jtbi.2001.2422 [DOI] [PubMed] [Google Scholar]
  • 12. Alon U. An Introduction to Systems Biology: Design Principles of Biological Circuits. New York: Chapman & Hall; 2006. [Google Scholar]
  • 13. Iglesias PA, Ingalls BP. Control Theory and Systems Biology. MIT Press; 2010. [Google Scholar]
  • 14. Ni XY, Drengstig T, Ruoff P. The control of the controller: Molecular mechanisms for robust perfect adaptation and temperature compensation. Biophys J. 2009;97(5):1244–53. 10.1016/j.bpj.2009.06.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Ang J, Bagh S, Ingalls BP, McMillen DR. Considerations for using integral feedback control to construct a perfectly adapting synthetic gene network. J Theor Biol. 2010;266(4):723–738. 10.1016/j.jtbi.2010.07.034 [DOI] [PubMed] [Google Scholar]
  • 16. Jolma IW, Ni XY, Rensing L, Ruoff P. Harmonic oscillations in homeostatic controllers: Dynamics of the p53 regulatory system. Biophys J. 2010;98(5):743–52. 10.1016/j.bpj.2009.11.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Huang Y, Drengstig T, Ruoff P. Integrating fluctuating nitrate uptake and assimilation to robust homeostasis. Plant, Cell & Environment. 2012;35(5):917–928. [DOI] [PubMed] [Google Scholar]
  • 18. Drengstig T, Jolma I, Ni X, Thorsen K, Xu X, Ruoff P. A basic set of homeostatic controller motifs. Biophys J. 2012;103(9):2000–2010. 10.1016/j.bpj.2012.09.033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Ang J, McMillen DR. Physical constraints on biological integral control design for homeostasis and sensory adaptation. Biophys J. 2013;104(2):505–515. 10.1016/j.bpj.2012.12.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Shoval O, Goentoro L, Hart Y, Mayo A, Sontag E, Alon U. Fold-change detection and scalar symmetry of sensory input fields. PNAS. 2010; p. 201002352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Drengstig T, Ni XY, Thorsen K, Jolma IW, Ruoff P. Robust Adaptation and Homeostasis by Autocatalysis. J Phys Chem B. 2012;116:5355–5363. 10.1021/jp3004568 [DOI] [PubMed] [Google Scholar]
  • 22. Briat C, Zechner C, Khammash M. Design of a synthetic integral feedback circuit: dynamic analysis and DNA implementation. ACS Synthetic Biology. 2016;5(10):1108–1116. 10.1021/acssynbio.6b00014 [DOI] [PubMed] [Google Scholar]
  • 23. Briat C, Gupta A, Khammash M. Antithetic integral feedback ensures robust perfect adaptation in noisy biomolecular networks. Cell Systems. 2016;2(1):15–26. 10.1016/j.cels.2016.01.004 [DOI] [PubMed] [Google Scholar]
  • 24. Aoki SK, Lillacci G, Gupta A, Baumschlager A, Schweingruber D, Khammash M. A universal biomolecular integral feedback controller for robust perfect adaptation. Nature. 2019; p. 1. [DOI] [PubMed] [Google Scholar]
  • 25. Fjeld G, Thorsen K, Drengstig T, Ruoff P. The Performance of Homeostatic Controller Motifs Dealing with Perturbations of Rapid Growth and Depletion. The Journal of Physical Chemistry B. 2017;121:6097–6107. 10.1021/acs.jpcb.7b01989 [DOI] [PubMed] [Google Scholar]
  • 26. Krishnan J, Floros I. Adaptive information processing of network modules to dynamic and spatial stimuli. BMC Systems Biology. 2019;13(1):32 10.1186/s12918-019-0703-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Ruoff P, Agafonov O, Tveit DM, Thorsen K, Drengstig T. Homeostatic controllers compensating for growth and perturbations. PLOS ONE. 2019;14(8):e0207831 10.1371/journal.pone.0207831 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Thorsen K, Agafonov O, Selstø CH, Jolma IW, Ni XY, Drengstig T, et al. Robust Concentration and Frequency Control in Oscillatory Homeostats. PLOS ONE. 2014;9(9):e107766 10.1371/journal.pone.0107766 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Moore-Ede MC, Sulzman FM, Fuller CA. The Clocks that Time Us: Physiology of the Circadian Timing System. Harvard Univ Press; 1982. [Google Scholar]
  • 30. Dunlap JC, Loros JJ, DeCoursey PJ. Chronobiology: Biological Timekeeping. Sinauer Associates; 2004. [Google Scholar]
  • 31. Lloyd D, Rossi EL. Ultradian Rhythms in Life Processes: An Inquiry into Fundamental Principles of Chronobiology and Psychobiology. Springer Science & Business Media; 2012. [Google Scholar]
  • 32.Radhakrishnan K, Hindmarsh AC. Description and Use of LSODE, the Livermore Solver for Ordinary Differential Equations. NASA Reference Publication 1327, Lawrence Livermore National Laboratory Report UCRL-ID-113855. Cleveland, OH 44135-3191: National Aeronautics and Space Administration, Lewis Research Center; 1993.
  • 33. Cannon W. Organization for physiological homeostatics. Physiol Rev. 1929;9:399–431. [Google Scholar]
  • 34. Efeyan A, Serrano M. p53: guardian of the genome and policeman of the oncogenes. Cell Cycle. 2007;6(9):1006–1010. 10.4161/cc.6.9.4211 [DOI] [PubMed] [Google Scholar]
  • 35. Luo Q, Beaver JM, Liu Y, Zhang Z. Dynamics of p53: A master decider of cell fate. Genes. 2017;8(2):66. [Google Scholar]
  • 36. Brady CA, Attardi LD. p53 at a glance. J Cell Sci. 2010;123(15):2527–2532. 10.1242/jcs.064501 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387(6630):296 10.1038/387296a0 [DOI] [PubMed] [Google Scholar]
  • 38. Asher G, Tsvetkov P, Kahana C, Shaul Y. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes & Development. 2005;19(3):316–321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Asher G, Shaul Y. p53 proteasomal degradation: poly-ubiquitination is not the whole story. Cell Cycle. 2005;4(8):1015–1018. 10.4161/cc.4.8.1900 [DOI] [PubMed] [Google Scholar]
  • 40. Asher G, Lotem J, Sachs L, Shaul Y. p53-dependent apoptosis and NAD(P)H: quinone oxidoreductase 1 In: Methods in Enzymology. vol. 382 Elsevier; 2004. p. 278–293. [DOI] [PubMed] [Google Scholar]
  • 41. Asher G, Lotem J, Sachs L, Kahana C, Shaul Y. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. PNAS. 2002;99(20):13125–13130. 10.1073/pnas.202480499 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Anwar A, Dehn D, Siegel D, Kepa JK, Tang LJ, Pietenpol JA, et al. Interaction of human NAD(P)H: quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J Biol Chem. 2003;278(12):10368–10373. 10.1074/jbc.M211981200 [DOI] [PubMed] [Google Scholar]
  • 43. Miki T, Matsumoto T, Zhao Z, Lee CC. p53 regulates Period2 expression and the circadian clock. Nature Communications. 2013;4:2444 10.1038/ncomms3444 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Gotoh T, Vila-Caballer M, Santos CS, Liu J, Yang J, Finkielstein CV. The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells. Mol Biol Cell. 2014;25(19):3081–3093. 10.1091/mbc.E14-05-0993 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Gotoh T, Kim JK, Liu J, Vila-Caballer M, Stauffer PE, Tyson JJ, et al. Model-driven experimental approach reveals the complex regulatory distribution of p53 by the circadian factor Period 2. PNAS. 2016;113(47):13516–13521. 10.1073/pnas.1607984113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Kawamura G, Hattori M, Takamatsu K, Tsukada T, Ninomiya Y, Benjamin I, et al. Cooperative interaction among BMAL1, HSF1, and p53 protects mammalian cells from UV stress. Communications Biology. 2018;1(1):204 10.1038/s42003-018-0209-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Ko CH, Takahashi JS. Molecular components of the mammalian circadian clock. Human Molecular Genetics. 2006;15(suppl_2):R271–R277. 10.1093/hmg/ddl207 [DOI] [PubMed] [Google Scholar]
  • 48. Albrecht U, Bordon A, Schmutz I, Ripperger J. The multiple facets of Per2 In: Cold Spring Harbor Symposia on Quantitative Biology. vol. 72 Cold Spring Harbor Laboratory Press; 2007. p. 95–104. [DOI] [PubMed] [Google Scholar]
  • 49. Hua H, Wang Y, Wan C, Liu Y, Zhu B, Yang C, et al. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Science. 2006;97(7):589–596. 10.1111/j.1349-7006.2006.00225.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature. 2003;421(6922):499 10.1038/nature01368 [DOI] [PubMed] [Google Scholar]
  • 51. Batchelor E, Loewer A, Lahav G. The ups and downs of p53: understanding protein dynamics in single cells. Nature Reviews Cancer. 2009;9(5):371 10.1038/nrc2604 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Geva-Zatorsky N, Rosenfeld N, Itzkovitz S, Milo R, Sigal A, Dekel E, et al. Oscillations and variability in the p53 system. Molecular Systems Biology. 2006;2(1). 10.1038/msb4100068 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Geva-Zatorsky N, Dekel E, Batchelor E, Lahav G, Alon U. Fourier analysis and systems identification of the p53 feedback loop. PNAS. 2010;107(30):13550–13555. 10.1073/pnas.1001107107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Batchelor E, Mock CS, Bhan I, Loewer A, Lahav G. Recurrent initiation: a mechanism for triggering p53 pulses in response to DNA damage. Molecular Cell. 2008;30(3):277–289. 10.1016/j.molcel.2008.03.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Fiscella M, Zhang H, Fan S, Sakaguchi K, Shen S, Mercer WE, et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. PNAS. 1997;94(12):6048–6053. 10.1073/pnas.94.12.6048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Fujimoto H, Onishi N, Kato N, Takekawa M, Xu X, Kosugi A, et al. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death and Differentiation. 2006;13(7):1170 10.1038/sj.cdd.4401801 [DOI] [PubMed] [Google Scholar]
  • 57. Mrosovsky N. Rheostasis The Physiology of Change. New York: Oxford University Press; 1990. [Google Scholar]
  • 58. Peng Y, Chen L, Li C, Lu W, Chen J. Inhibition of MDM2 by HSP90 contributes to mutant p53 stabilization. J Biol Chem. 2001;276(44):40583–40590. 10.1074/jbc.M102817200 [DOI] [PubMed] [Google Scholar]
  • 59. Karawajew L, Rhein P, Czerwony G, Ludwig WD. Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. Blood. 2005;105(12):4767–4775. 10.1182/blood-2004-09-3428 [DOI] [PubMed] [Google Scholar]
  • 60. Rivas CI, Wisniewski D, Strife A, Perez A, Lambek C, Bruno S, et al. Constitutive expression of p53 protein in enriched normal human marrow blast cell populations. Blood. 1992;79(8):1982–1986. [PubMed] [Google Scholar]
  • 61. Möglich A, Ayers RA, Moffat K. Structure and signaling mechanism of Per-ARNT-Sim domains. Structure. 2009;17(10):1282–1294. 10.1016/j.str.2009.08.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Ono D, Honma S, Nakajima Y, Kuroda S, Enoki R, Honma Ki. Dissociation of Per1 and Bmal1 circadian rhythms in the suprachiasmatic nucleus in parallel with behavioral outputs. PNAS. 2017;114(18):E3699–E3708. 10.1073/pnas.1613374114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Wilkie J, Johnson M, Reza K. Control Engineering. An Introductory Course. New York: Palgrave; 2002. [Google Scholar]
  • 64. Batchelor E, Loewer A. Recent progress and open challenges in modeling p53 dynamics in single cells. Current Opinion in Systems Biology. 2017;3:54–59. 10.1016/j.coisb.2017.04.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Porter JR, Fisher BE, Batchelor E. p53 pulses diversify target gene expression dynamics in an mRNA half-life-dependent manner and delineate co-regulated target gene subnetworks. Cell Systems. 2016;2(4):272–282. 10.1016/j.cels.2016.03.006 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Robert S Weiss

5 Feb 2020

PONE-D-19-35675

Frequency switching between oscillatory homeostats and the regulation of p53

PLOS ONE

Dear Ruoff,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Both reviewers are in agreement that the manuscript is in need of major revisions.  The reviewers provide multiple suggestions for modifications to figures, text (rationale, assumptions, etc), and mathematical equations that will greatly improve clarity.  In particular, the reviewers note several places where the writing could be improved to eliminate ambiguities and inaccuracies.  Another example of this issue comes from the abstract: “Mdm2 on its side keeps p53 at a maximum level to avoid premature apoptosis”.  I encourage the authors to not only respond to the reviewer feedback but also carefully review the entire text before submitting a revised manuscript.

We would appreciate receiving your revised manuscript by Mar 21 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Robert S. Weiss

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Summary:

Peter Ruoff and Nobuaki Nishiyami present a novel model of p53 oscillations in terms of three interlocked negative feedback loops involving Per2 (Circadian Oscillations), ATM* (Radiation Damage Sensing), and Mdm2 (p53 ubiquitinoylation and degradation). The work further develops their theoretical paradigm cited in [16], [17], [18], [21], [25], [27], [28], and [53]. The work also builds upon their biological model previously presented in [16] and [28]. The key findings of this work include demonstration of a multi-step response controlled by the three competing rheostats set by Per2, ATM*, and Mdm2 that is also associated with frequency switching from p53 oscillations associated with Circadian rhythms to faster cycling. The authors frame why oscillations occur in terms of integral control and develop criteria to determine whether interlocked controllers will perform cooperatively, leading to optimal control, or competitively, leading to integral windup.

The papers raised some interesting points but the analyses need to address some important points:

Major Concerns:

Define Type 3, Type 1, and Type 5 controllers in the introduction. This terminology could be confusing because, as an example, Uri Alon’s Intro to Systems Biology describes totally different motifs with the same 1-8 notation. It’s possible that other sources could also define these differently. Further, these motifs only apply to two species systems.

Figure 2 is not intuitive and notationally confusing. In the current configuration, it looks like there is interconversion between A and E_in since k_1,k_2 look like a reversible reaction between them. Change this to something like the empty set ∅ to indicate generation and degradation. Further, you use the Michaelis/Saturation constant K_M multiple times. Denote these as K_(M,i) where i indicates the reaction number. E_out degradation, you list rates k_4 and k_5, but from equation 2, k_5 appears to be a Michaelis constant, similarly with k_10. What does K_I1 denote? Why are letters being used instead of numbers at this point? State that K_M will be omitted in the first model but will be included in later, more complex models.

The authors rely significantly on self-citations notably 16, 18, and 28. Please acknowledge that these are self-citations (e.g. “In [16], we previously derived…”). This would also clarify why the authors refer to the motifs using such specific terminology which might be unfamiliar to the reader as commented on in major revision 1.

Graphically, many of the figures appear to be low resolution. Plots are presented as 3D surfaces that are impossible to read rather than pseudo-colormaps. Other figures appear inappropriately vectorized and show distortions upon scaling. Further, the notation and depiction of reaction networks in Figures 2 and 7 is extremely confusing.

Based on Reference 16, the period derived there is P=2π/(k×k_adapt ) (just below Eq. 5 in Ref 16). Unless I am missing something in that source, why does the equation for period involve a square root as if a geometric average was taken? Is there an error in either this manuscript or the author’s previous article?

Further, in their derivations the authors assume that K_M,K_M^'≪A, this negates the need to even use a Michaelis-Menten form since the reactions would become pseudo-zero order.

Figure 5 showed fluctuations of A. You were previously able to provide reasonable estimates of the average values of 〈A〉,〈E_out 〉,and 〈E_in〉. Can you analytically estimate or predict the magnitude of fluctuations in this figure?

Amend Figure 6 with an idealized/simplified schematic of Figure 7 showing how all 3 feedback motifs affect P53 similar to Figure 2.

Amend Figure 7 with boxes showing which parts constitute the Motif 1, 3, and 5 feedback systems.

No justification of the rate parameters is provided besides that they exist in a region of parameter space expected to provide oscillatory, integral control. In the methods section, please clearly cite previous models and parameter sets from which this current model was constructed.

As opposed to intrinsic stochasticity in the gene circuit, I think there is the question of parameter heterogeneity. Given that 40% of cells treated with the same radiation dose do not respond in an oscillatory fashion, I feel like a Monte Carlo parameter sweep (even if deterministic integration ignoring intrinsic noise is employed) of certain critical parameters like k_30 should be performed in order to investigate the bifurcation behavior of oscillatory/non-oscillatory cells and to provide potential mechanisms for why this has been experimentally observed.

Figure 11 needs to be significantly reworked for clarity. This is the first time all 8 configurations are introduced in the paper in spite of the fact that the authors expect the reader to be familiar with all of them in the introduction. Further, the sign structure arguments are confusing. It may actually be easier for the author to specify the differential equations and the set point for each configuration so that the reader can algebraically verify the sign structure.

In Figure 12c, I understand why a signal less than p53-max stress would decrease to p53-min stress since both signs are negative. However, it seems like Per2 would pull the p53 level towards the homeostatic condition while ATM* would pull it to the min damage condition. Why isn’t this an example of integral windup?

Minor Revisions:

Approximate ≈ or limit → should be used in Equations 4 and 5 since they are subject to the approximations/limiting arguments described in the preceding paragraph. In Reference 16, which was your own previous paper, you make this distinction.

Figure 3 may be more legible as a 2D pseudo color plot with all 3 side by side. 3D surfaces tend to be harder to read. Also, superimposing two 3D surfaces cannot be read.

Figure 5 should be revised as suggested for Figure 3 in minor revision 2. You already appear to have the pseudo-color plots beneath the surfaces. Therefore, you should just use the 2D pseudo-colors.

Grammatical error line 138, change to “degradation of p53, thereby stabilizing p53.”

Don’t denote the radiation damage by k_30. This makes it easily confusable as a reaction rate.

Don’t denote Michaelis constants with the same notation as rate constants.

Grammatical error line 177. Change to “In stressed cells, several…”

The graphical resolution of Figure 8 looks low quality. It seems like things were scaled up inappropriately.

Throughout Figure 8, the resolution of the graphs near the phase transition is insufficient. While the Circadian and high stress states are oversampled, the region around the two phase transitions could benefit from enhanced simulation resolution.

Reviewer #2: The author proposes a dynamical model of the p53 regulation, accounting for three interlocked feedback loops involving p53, Per2, ATM and Mdm2, to illustrate frequency switches that can occur in such type of homeostatic systems in response to environmental signals. They use a structural approach in terms of the analysis of specific motif interplays to interpret the behavior of such systems combining different so called “inflow” and “outflow” controllers.

Although the use of the controller’s theory applied to biological systems to decipher their dynamical behavior is interesting, I believe that the manuscript needs major revisions before being accepted in PloS One. The following major concerns should be addressed before considering the manuscript for publication:

1- The authors should rework in depth the structure and the writing of the manuscript. The biological data used to build the model, the assumptions made, and the analysis of the model outcome should be more clearly delineated. Moreover, some parts of the paper resembles a catalogue of descriptions (for example p.9) which make the manuscript unclear and hard to follow. The description of the model and its analysis are not separated clearly enough, which makes the outcome of the work confusing.

2- Some statements need more explanations/justifications. For example, there is a lack of explanations of

the type of functions (Michaelis-Menten, linear, product of Michaelis-Menten,…) used to model the processes appearing in the differential equations. Moreover, some biological data used to built the model is lacking (role of Bmal/Clk, dimerization of Per1 and Per2).

3- The level of English should be strongly improved. For example: “(K_m not used)” l.81; “we arrive at” l.171 ; “the other rate equations are” l.205; “has apparently the function” l.291,...

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Robert S Weiss

5 May 2020

Frequency switching between oscillatory homeostats and the regulation of p53

PONE-D-19-35675R1

Dear Dr. Ruoff,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Robert S. Weiss

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Both reviewers found the manuscript to be significantly improved, although the two reviewers differed somewhat on their overall assessment.  Reviewer 2 raised a few issues with the revised manuscript that follow on comments from the original submission.  My assessment is that the revised publication does meet the specific PLOS ONE criteria for publication, with the suggestions of reviewer 2 being reasonable but primarily stylistic in nature.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed all of my questions thoroughly. The figures they altered are much clearer in terms of breaking down the controller motifs.

Reviewer #2: The author proposes a dynamical model of the p53 regulation, accounting for three interlocked feedback loops involving p53, Per2, ATM and Mdm2, to illustrate frequency switches that can occur in such type of homeostatic systems in response to environmental signals. They use a structural approach in terms of the analysis of specific motif interplays to interpret the behavior of such systems combining different so called “inflow” and “outflow” controllers.

Compared to the previous version of the manuscript, there have been substantial efforts to complete and improve the manuscript and a slight effort to improve its clarity with the incorporation of a subsection in the Material and Methods highlighting the outline of the paper. Moreover, some lacking biological data used to build the model (role of Bmal/Clk, dimerization of Per1 and Per2) are now described in the manuscript.

However, I still think that the manuscript needs some major revisions before being accepted in PloS One. The following major concerns should be addressed before considering the manuscript for publication:

1. I’m a bit confused concerning the sections entitled “Cannon's definition of homeostasis and its realization by inflow and outflow controllers. The non-oscillatory case” and “Oscillatory control mode” as it does not clearly appear to me whether it corresponds to an original outcome of the work or a recall of previous works on the realization of homeostasis by inflow and outflow controllers. The authors should clarify this point. If it is just a recall of previous works, I would strongly suggest to move this part to supplementary materials (which would moreover clarify the outcome of the work), with references to this part in the rest of the manuscript whenever needed.

2. The authors should still improve the structure and the writing of the manuscript. The description of the model, the hypothesis and choices made (notably for the parameter values), the results and its analysis are still not separated clearly enough, making the outcome of the work still confusing. Again, some parts of the paper are more like a “catalogue” of descriptions and results, making the manuscript hard to follow. Maybe additional subsections should be considered to clarify the manuscript, for example: a part devoted to the description of the p53 model (biological background, mathematical model proposed, biological data on which the model rely); another on the hypothesis and choices made in particular for the setting of the parameters; and another one focusing on the main results with the most relevant simulation results. I would also suggest to move details of mathematical calculations in supplementary material.

3. There is still a lack of explanations/justifications of the type of functions (Michaelis-Menten, linear, product of Michaelis-Menten,…) used to model the processes appearing in the differential equations.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Xiling Shen

Reviewer #2: No

Acceptance letter

Robert S Weiss

6 May 2020

PONE-D-19-35675R1

Frequency switching between oscillatory homeostats and the regulation of p53

Dear Dr. Ruoff:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Robert S. Weiss

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Matlab. Matlab programs.

    A zip-file with Matlab programs showing the results from Figs 5a, 5b, 10a–10d and 11a–11c (left panels).

    (ZIP)

    S1 Gnuplot. Interactive visualization.

    A zip-file with a gnuplot script and an avi video file showing an interactive view of Fig 4.

    (ZIP)

    S2 Gnuplot. Interactive visualization.

    A zip-file with a gnuplot script and avi video files showing interactive views of panels a-d in Fig 6.

    (ZIP)

    S1 Text. Harmonic approximation of period lengths and amplitudes of oscillatory m3 and m5 controllers.

    (PDF)

    S2 Text. Determination of set-point and period length of the ATM* controller.

    (PDF)

    S3 Text. Combined m1 and m5 controllers and their cooperative and wind-up behaviors.

    (PDF)

    S4 Text. Steady state levels of the model as a function of stress level s when feedback loops are non-oscillatory.

    (PDF)

    Attachment

    Submitted filename: reply_reviewers.pdf

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES